ARTICLE | Company News
Cevec, Paragon Bioservices Inc. deal
March 17, 2014 7:00 AM UTC
Cevec said that an evaluation by CRO Paragon showed Cevec's CAP cells were able to produce "very high" titers of respiratory syncytial virus (RSV). Cevec said the RSV produced in the CAP cells showed ...